NGM Biopharmaceuticals, Inc. Current Ratio 2018-2023 | NGM
NGM Biopharmaceuticals, Inc. current ratio from 2018 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.16B | $0.02B | 7.79 |
| 2023-09-30 | $0.18B | $0.02B | 7.92 |
| 2023-06-30 | $0.20B | $0.03B | 7.19 |
| 2023-03-31 | $0.24B | $0.04B | 6.40 |
| 2022-12-31 | $0.29B | $0.05B | 6.04 |
| 2022-09-30 | $0.32B | $0.05B | 6.50 |
| 2022-06-30 | $0.32B | $0.04B | 7.50 |
| 2022-03-31 | $0.34B | $0.05B | 7.58 |
| 2021-12-31 | $0.38B | $0.06B | 6.18 |
| 2021-09-30 | $0.40B | $0.06B | 6.86 |
| 2021-06-30 | $0.40B | $0.05B | 8.95 |
| 2021-03-31 | $0.43B | $0.04B | 10.57 |
| 2020-12-31 | $0.31B | $0.04B | 7.24 |
| 2020-09-30 | $0.30B | $0.04B | 8.01 |
| 2020-06-30 | $0.32B | $0.03B | 9.57 |
| 2020-03-31 | $0.34B | $0.03B | 11.89 |
| 2019-12-31 | $0.36B | $0.04B | 8.94 |
| 2019-09-30 | $0.36B | $0.04B | 9.00 |
| 2019-06-30 | $0.37B | $0.04B | 9.53 |
| 2019-03-31 | $0.20B | $0.04B | 4.64 |
| 2018-12-31 | $0.22B | $0.04B | 5.17 |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.00B | 0.00 | |
| 2017-12-31 | $0.00B | 0.00 | |
